Document Detail


Predicting Left Ventricular Recovery After Replacement of a Regurgitant Aortic Valve in Pediatric and Young Adult Patients: Is It Ever Too Late?
MedLine Citation:
PMID:  23052669     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The management of pediatric and adolescent patients with pure aortic valve regurgitation remains challenging and controversial (Christos et al., Eur J Cardiothorac Surg 17:125-133, 2000; Gersony and Sommerville, ACC Curr J Rev 31:97-98, 2000; Hasaniya et al., J Thorac Cardiovasc Surg 127:970-974, 2004; Sabet et al., Mayo Clin 74:14-26, 1999; Tweddell et al., J Thorac Cardiovasc Surg 129:551-558, 2005). We evaluated pediatric and young adult patients who underwent aortic valve replacement (AVR) primarily for aortic regurgitation in an effort to identify preoperative echocardiographic variables that are predictive of left ventricular (LV) recovery following AVR. Twenty-one patients with severe aortic valve regurgitation who underwent AVR were identified. Retrospective chart review for each patient was performed and transthoracic echocardiograms prior to and 6-months after AVR were analyzed. Improvement in LV size based on preoperative LV end-systolic dimension index when compared to 6-months post-AVR was observed in 68 % of the patients. Patients with persistent dilation of their left ventricles had a greater preoperative LV end-systolic dimension index (p ≤ 0.05), a greater preoperative LV end-systolic dimension z-score (p ≤ 0.002), and a lower preoperative ejection fraction (EF) (p ≤ 0.001). A similar trend was present between the two cohorts in regards to LV end-diastolic parameters (LV end-diastolic dimension index and z-score), with patients with abnormal LV size at 6-month follow-up having larger preoperative dimensions. Increasing LV systolic dimensions and declining EF appear to be predictors of poor LV recovery following AVR in pediatric and young adult patients. LV end-systolic indices appear to be more predictive than LV end-diastolic indices. AVR should be performed prior to severe LV enlargement defined as an LV end-systolic dimension z-score >4.5.
Authors:
Daniel A Cox; Kara Walton; Peter J Bartz; James S Tweddell; Peter C Frommelt; Michael G Earing
Related Documents :
14751859 - Left atrial conduit volume is generated by deviation from the constant-volume state of ...
1829319 - Relation of left ventricular volume and function over one year after acute myocardial i...
1960969 - Assessment of cardiac function using radionuclide techniques--theory, technical conside...
15073479 - Comparison of changes in ejection fraction to changes in impedance cardiography cardiac...
9313599 - Congestive heart failure in patients with coronary artery disease: the gender paradox.
4018179 - Effect of long-term administration of digoxin on exercise performance in chronic airflo...
23936589 - Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion dam...
16863609 - Long term clinical outcomes in patients with moderate renal insufficiency undergoing st...
21676059 - Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-9
Journal Detail:
Title:  Pediatric cardiology     Volume:  -     ISSN:  1432-1971     ISO Abbreviation:  Pediatr Cardiol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003849     Medline TA:  Pediatr Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac Resynchronization by Repositioning of a Ventricular Epicardial Lead in a Patient With Hypopl...
Next Document:  Efficacy of an Interleukin-1? Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis.